WHAT RESEARCH HAS FOUND
What studies tell you about KLOW peptide
Studies from 2024–2026 tested the four ingredients one at a time. You’ll see who was studied, what changed, and what remains unknown.
What each ingredient changed on its own
Studies in animals and cells tested KPV, GHK-Cu, BPC-157 and TB-500 one by one. They looked at the bowel, skin, tendons, ligaments, stomach, and wounds.
KLOW peptide puts all four in one research vial. A peptide is a short string of the same small building blocks that make proteins.
The vial most often listed holds 80 mg. It has 50 mg of GHK-Cu and 10 mg each of BPC-157, TB-500 and KPV.
In mice, KPV eased swelling and sores in the bowel. In a dish, it also calmed signs of swelling in gut cells.
GHK-Cu carries copper used to make collagen, the firm protein that supports skin. BPC-157 helped injured tendons, ligaments, and stomach tissue, mostly in animals.
TB-500 is a short piece cut from a larger protein used in wound studies. Most strong results came from the larger protein, not the short piece itself.
No fair test has put all four ingredients together. I'd keep that gap in mind when broad claims come up.
People also post wanted and unwanted effects online. The effects page separates those reports from study findings.
At your next visit, ask which single ingredient was tested. Then ask whether the same result is known in a person like you.
While you discuss the four ingredients with your clinician, ask who was studied, what changed, how long the work lasted, and what it still can’t tell you about your own health.
What is KLOW peptide, and what does the vial hold?
KLOW peptide is a dry research mix of KPV, GHK-Cu, BPC-157 and TB-500. Each is a peptide, or a short string of protein building blocks called amino acids.
Water turns the dry powder into one liquid. The four ingredients remain their own chemicals; they don’t join to make one new drug.
BPC-157 is the ingredient with a 15-amino-acid chain, meaning that many protein building blocks linked in a row. The usual 80 mg vial lists 50 mg of GHK-Cu and 10 mg of BPC-157, 10 mg of TB-500, and 10 mg of KPV.
The FDA hasn’t approved KLOW as a drug. There isn’t one official recipe for the blend.
KPV calmed signs of swelling in gut cells and immune-system cells in a dish [3]. That lab result doesn’t say whether your gut would feel better.
GHK-Cu carries copper used to make collagen, which helps give skin its strength. Other dish work looked at how skin cells repair their DNA [4][5].
In animal work, that peptide helped new blood reach hurt tissue [2][6]. Study 2 tested the same tendon ingredient. Separate work tested thymosin beta-4, the full wound protein from which TB-500 is cut [1].
The full protein helped skin cells move into wounds. That doesn’t prove the much shorter piece acts like thymosin beta-4.
No fair test has compared the whole mix with one peptide, fewer peptides, or placebo. At your appointment, ask what evidence applies to your own concern.
During a talk with your clinician about the vial, ask who was studied, what changed, how long the work lasted, and what it still can’t tell you about your own health.
What KLOW may change, and what it can’t prove
KLOW adds KPV to the three peptides in GLOW and WOLVERINE. In mice, KPV eased colitis, which means swelling and sores in the bowel [3].
The mice drank water with 100 micromoles of KPV per liter. That small lab measure isn’t a human dose.
The same study used human gut cells in a dish. KPV calmed signs of swelling there, but no person took the blend.
GHK-Cu is about 62.5% of the usual vial. It is the largest ingredient by weight.
A 2018 dish study used 1–10 nanomoles per liter, a very small lab amount. About 31.2% of the cell instructions changed by 50%-or-greater, meaning by half or more [5].
In one group, 41 cell instructions became more active and 1 became less active. The test didn’t show whether those changes helped or harmed a person.
KPV and GHK-Cu may leave your body faster than BPC-157. TB-500 may not act like thymosin beta-4, the full wound protein from which it is cut.
No study has checked whether the four-part blend, including BPC-157 and TB-500, stays sound in one liquid. Copper in GHK-Cu might also react with that liquid.
At your next visit, ask which ingredient was tested and in whom. Four names on one label don’t turn one finding into four.
As your clinician reviews the cell work with you, ask who was studied, what changed, how long the work lasted, and what it still can’t tell you about your own health.
What KLOW peptide benefits were seen, and in whom
The strongest findings belong to one ingredient at a time. They don’t show that the four-part KLOW blend works in people.
In rats, BPC-157 helped fully cut Achilles tendons heal [2]. Researchers checked strength, use, and the repaired tendon under a microscope.
The rats received 10 micrograms, 10 nanograms, or 10 picograms. Those are tiny lab weights, and none is a human dose.
A 2026 review gathered animal studies of BPC-157 for pain and tissue repair [7]. A review can weigh old work, but it can’t replace a KLOW trial.
In rats with deep skin wounds, the full protein behind TB-500 sped skin closing. Wounds closed 42% more at 4 days and up to 61% more at 7 days [1].
Just 10 picograms made skin cells move 2–3-fold, or two to three times as far in a dish. That shows movement in a dish, not how a person’s wound would heal.
Most of this work used thymosin beta-4, the full 43-amino-acid protein, meaning its many linked protein building blocks. The short piece is only one part of thymosin beta-4.
A second paper had the same limit. Researchers haven’t shown that TB-500 acts like the full protein.
Skin studies found more collagen in 70% of women given GHK-Cu. The rates were 50% with vitamin C and 40% with retinoic acid [4].
The studies also saw changes in loose skin, fine lines, and wrinkle depth. Collagen is the firm protein that helps support skin.
Blood GHK fell from about 200 nanograms per milliliter at age 20 to about 80 nanograms per milliliter by age 60. That age link gives no goal for someone late in life and doesn’t prove a benefit.
In 2024, mice with short-term and long-term colitis got KPV with FK506 [8]. That drug calms the immune system.
The pair helped the gut lining and eased signs of swelling more than either alone. The test was in mice, not people using the four-part KLOW mix.
People also post their own results. Those reports aren’t controlled studies; the KLOW effects page keeps them separate.
I'd ask your clinician which result matches your concern. Then ask how much is still unknown for someone your age.
When claimed benefits come up with your clinician, ask who was studied, what changed, how long the work lasted, and what it still can’t tell you about your own health.
What changes when you compare KLOW vs glow
GLOW contains GHK-Cu, BPC-157 and TB-500. KLOW has those three plus KPV, which has been studied for bowel swelling.
Some users say the added KPV feels calming. Their reports aren’t proof because no study has compared the two blends.
The usual KLOW vial holds 80 mg, with 10 mg of KPV. A GLOW vial with the same total weight can leave more room for its three ingredients.
If you’re comparing them, ask for the amount of each peptide. Shared names don’t make two vials equal.
I'd also ask what the visit, follow-up, and total cost involve. No study can tell you which blend would help you.
Before you settle on a blend with your clinician, ask who was studied, what changed, how long the work lasted, and what it still can’t tell you about your own health.